Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern

OBJECTIVES: The BIV1-CovIran vaccine is highly effective against COVID-19. The neutralizing potency of all SARS-CoV-2 vaccines seems to be decreased against variants of concern. We assessed the sensitivity of the Alpha (B.1.1.7), Beta (B.1.351), and Delta (B.1.617.2) variants to neutralizing antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehi, Mohammadreza, Hosseini, Hamed, Jamshidi, Hamid Reza, Jalili, Hasan, Tabarsi, Payam, Mohraz, Minoo, Karimi, Hesam, Lotfinia, Majid, Aalizadeh, Reza, Mohammadi, Mehrdad, Ramazi, Shahin, Abdoli, Asghar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893932/
https://www.ncbi.nlm.nih.gov/pubmed/35248745
http://dx.doi.org/10.1016/j.cmi.2022.02.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893932/
https://www.ncbi.nlm.nih.gov/pubmed/35248745
http://dx.doi.org/10.1016/j.cmi.2022.02.030

Ejemplares similares